Jim Roberts and Brian Finrow (Lumen Bioscience)

Lu­men Bio­science reels in $16M Se­ries B to 'de­moc­ra­tize' bi­o­log­ics

It all start­ed with spir­uli­na — a nu­tri­ent-packed su­per­food pop­u­lar on the West Coast.

The pho­to­syn­thet­ic mi­croal­gae has been com­mer­cial­ly farmed since the 1970s. But Lu­men Bio­science co-founders Bri­an Fin­row and Jim Roberts aren’t look­ing to sup­ple­ment their di­ets. They be­lieve spir­uli­na can be en­gi­neered to de­liv­er ther­a­peu­tic pro­teins and treat dis­eases like trav­el­er’s di­ar­rhea, norovirus and C. dif­fi­cile col­i­tis. And Lu­men just reeled in a $16 mil­lion Se­ries B to prove it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.